Brief: Zhongzhi Pharmaceutical Posts HY Profit Attributable Of RMB47 Mln
29/08/2018 16:03
Aug 29 (Reuters) - Zhongzhi Pharmaceutical Holdings Ltd
3737.HK :
* HY REVENUE RMB556.7 MILLION VERSUS RMB431.5 MILLION
* HY PROFIT ATTRIBUTABLE RMB47 MILLION VERSUS RMB38.5
MILLION
* RECOMMENDS INTERIM DIVIDEND OF HK2.65 CENTS PER SHARE & A
SPECIAL DIVIDEND OF HK1.70 CENTS PER SHARE
Source text for Eikon: ID:nHKS9Z1L6g
Further company coverage: 3737.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zhongzhi Pharmaceutical Holdings
See all newsBrief: Zhongzhi Pharmaceutical Expects Over 70% Decrease In 2025 Net Profit
Brief: Zhongzhi Pharmaceutical Expects 90% Decrease In HY Net Profit
Brief: Zhongzhi Pharmaceutical Posts HY Profit Attributable RMB83.4 Million
Brief: Zhongzhi Pharmaceutical Sees Decrease In Net Profit Of 40% For HY
Brief: Zhongzhi Pharmaceutical Declares Final Dividend Of HK3 Cents Per Share